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03. X-8 CRYSTALLOGRAPHIC AND ~lOLECULAR MODELLING 
STUDIES ON POLYCYCLIC AROMATIC HYDROCARBONS. Stephen 
Neid1e, CRC Research Group, King's College London, 
WC2B 5RL, U.K. 
Polycyclic hydrocarbons do not themselves bind to nu-
cleic acids, their likely biological targets. Instead, 
a complex series of metabolic steps leads to reactive 
speCies, typified by the 7,S-dio1 9,10-ep?xides of benzo-
(a)pyrene. This compound has four stereolsomers, wlth 
widely differing carcinogenicities and reactivities to 
DNA. Crystallographic studies have now been performed 
on the racemates of both ~ and anti isomers; the 
latter is probably biologically the more significant. 
No structural data is as yet available on benzo(a)pyrene-
oligonucleotide adducts. He have used the X-ray data on 
the metabolite structures in computerized molecular 
modelling studies on both the covalent and interca1ative 
adducts of benzo(a)pyrene. Results of this work will be 
presented, with especial reference to dif!er~nces sh~wn 
by the (+) and (-) enantiomers of the antl dl01 epoxlde. 
03. X-9 ELECTRON DENS ITY ~1APP I NG OF t10DELS FOR THE 
ACTIVATED METABOLITES OF CARCINOGENIC POLYAROMATIC 
HYDROCARBONS. By C. L. Klein, Dept. of Chemistry, 
Xavier University, New Orleans, Louisiana 70125 and 
E: D. Stevens, Dept. of Chemistry, University of New 
Orleans, New Orleans, Louisiana 7014S. 
Many po1yaromatic hydrocarbons(PAH), such as benzo(a)-
pyrene(BP), are known to be environmental pollutants and 
potent chemical carcinogens. The most active forms of 
the molecules are metabolic derivatives of the parent 
hydrocarbons. Although a large number of metabolites of 
BP have been identified, the ultimate carcinogen is 
believed to be a dihydrodiol epoxide. 
We have begun a study of the electron density distribu-
tion of a series of naphthalene derivatives which model 
the metabolites of BP. One of these, anti-3,4-dihydroxy-
1,2,3 ,4-tetrahydronaphtha1 ene-1 ,2-oxi de(NDE), has been 
chosen as a small molecule model for the ultimate car-
cinogenic metabolite of BP. Room temperature x-ray data 
show extens i ve structural s imil ariti es between NDE and 
the dihydrodio1 epoxide of BP. To map the electron 
density distribution, extensive high-resolution x-ray 
data (sin B/A < 0.S5 A-1) have been collected at 110 K. 
Phases for the observed structure factors in the acen-
tric space group Pca21 have been taken from the model 
phases of a MOLLY mu1tipo1e deformation refinement. 
Maps of the electron deformation density at the reactive 
site of the diol epoxide will be presented. From the 
electron distribution and the electrostatic potential, a 
molecular property which may also be obtained, we hope 
to predict sites and modes of chemical reactivity and to 
correlate this information with carcinogenic activity. 
Research sponsored by the Cancer Association of Greater 
New Orl eans. 
03. X-l0 STEREOCHEMICAL PROPERTIES OF NUCLEOSIDES 
ALKYLATED BY ACTIVATED CARCINOGENS. Jenny P. G1usker, 
H. L. Carrell and John J. Stezowski, Institute for 
Cancer Research, Fox Chase Cancer Center, 7701 Burholme 
Avenue, Philadelphia, Pennsylvania 19111, U.S.A. and 
Universitat Stuttgart, D-7000 Stuttgart SO, Federal 
Republic of Germany. 
The mechani sm of chemi ca 1 carci nogenesi s by "acti vated" 
carCinogenic polycyclic aromatic hydrocarbons is 
believed to involve alkylation of DNA. A series of 
adenosines and 2'-deoxyadenosine substituted at N6 by 
related ara1ky1s of differing carCinogenic potential has 
been prepared. We report here the crystal structure 




2'-deoxyadenosine. Results are compared with those for 
a previously published analYSis l, N6_(12-methY1benz[~]­
anthracenyl-7-methyl)-2'-deoxyadenosine. All five com-
pounds have the ~-conformationa1 relationship between 
the sugar and the base. The overall conformations of 
all five copounds are similar, the base lying approxi-
mately perpendicular to the polycyclic aromatic ring 
system. The packing consists of alternations of adenine 
and polycyclic aromatic ring systems in columns through 
the crystal. The propensity of these adducts to adopt 
the ~-conformation may be indicative of a preference 
of alky1ated DNA for the Z-conformation (even if the 
form that is initially attacked is B-DNA). Computer-
based molecular modeling techniques have been used to 
construct a tentative model of the interaction of 
aralkyl substituents with Z-DNA. 
Research supported by the American Cancer Society 
(BC-242), The National of Health (CA-10925), the 
Deutsche Forschungsgemeinschaft (STE 230/4-1) and 
the Verband der Chemischen Industrie E.V: 
03.X-ll DNA AS TARGET MOLECULE FOR DRUGS 
AND ACTION OF THE ANTIMETABOLITE 5-AZAURIDINE. 
By W. Saenger, Institut fOr Kristallographie, 
Freie Universitat Berlin, Takustr. 5, 
D-1000 Berlin 33. 
In nature there are two types of nucleic acids, 
RNA and DNA. The latter occurs in two princi-
pal right-handed double helical forms A and B 
which exhibit sugar puckerings C3'-endo in A 
and C2'-endo in B. and display different he-
lical parameters. The biologically active spe-
cies is B-DNA which is found in superhelical 
form in chromatin, is of impcrtance for pro-
tein-DNA interactions and is the target for 
drug intercalation. If B-DNA is dehydrated or 
subjected to high salt conditions, it trans-
forms into A-DNA which is transiently observed 
in DNA transcription when DNA/RNA hybrids 
exist. The latter as well as double helical 
RNA can adopt only the A-form for reasons not 
yet fully understood. If DNA has a certain al-
ternating sequence poly(dG-dC), it can trans-
form into Z-DNA, a left-handed double helix. 
In this form, the Watson-Crick base-pair is 
still maintained, yet the sugar puckerings al-
ternate C3'-endo for dG and C2'-endo for dC. 
The C8-position of guanine is exposed at the 
periphery of the Z-DNA helix and can become a 
prime target for drugs such as aflatoxin. 
The building blocks of nucleic acids, called 
nucleotides, are themselves biologically 
active. They can be modified chemically and, 
in case of 5-azauridine, display anti leukaemic 
action. Structure analyses have demonstrated 
that this drug exhibits unusual conformation 
which explains its biological action. 
